Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure.
El Alam S, Pena E, Aguilera D, Siques P, Brito J.
Int J Mol Sci. 2022 Oct 21;23(20):12656. doi: 10.3390/ijms232012656.
Pathology and pathobiology of pulmonary hypertension: current insights and future directions.
Guignabert C, Aman J, Bonnet S, Dorfmüller P, Olschewski AJ, Pullamsetti S, Rabinovitch M, Schermuly RT, Humbert M, Stenmark KR.
Eur Respir J. 2024 Oct 31;64(4):2401095. doi: 10.1183/13993003.01095-2024. Print 2024 Oct.
Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development.
Knoepp F, Abid S, Houssaini A, Lipskaia L, Gökyildirim MY, Born E, Marcos E, Arhatte M, Glogowska E, Vienney N, Günther A, Kraut S, Breitenborn-Mueller I, Quanz K, Fenner-Nau D, Derumeaux G, Weissmann N, Honoré E, Adnot S.
Circ Res. 2025 Apr 25;136(9):1031-1048. doi: 10.1161/CIRCRESAHA.124.325475. Epub 2025 Apr 4.
Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia.
Nakamura K, Akagi S, Ejiri K, Taya S, Saito Y, Kuroda K, Takaya Y, Toh N, Nakayama R, Katanosaka Y, Yuasa S.
Int J Mol Sci. 2025 Jan 20;26(2):835. doi: 10.3390/ijms26020835.
Persistent pulmonary hypertension of the newborn.
Mandell E, Kinsella JP, Abman SH.
Pediatr Pulmonol. 2021 Mar;56(3):661-669. doi: 10.1002/ppul.25073.
Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
Born E, Lipskaia L, Breau M, Houssaini A, Beaulieu D, Marcos E, Pierre R, Do Cruzeiro M, Lefevre M, Derumeaux G, Bulavin DV, Delcroix M, Quarck R, Reen V, Gil J, Bernard D, Flaman JM, Adnot S, Abid S.
Circulation. 2023 Feb 21;147(8):650-666. doi: 10.1161/CIRCULATIONAHA.122.058794. Epub 2022 Dec 14.
Right Ventricular Dysfunction in Lung Disease/Hypoxia-Associated Pulmonary Hypertension.
Shima H, Tsujino I, Nakaya T, Nakamura J, Igarashi-Sugimoto A, Sato T, Watanabe T, Ohira H, Hisada R, Kato M, Tsuneta S, Yokota I, Konno S.
J Am Heart Assoc. 2025 Aug 19;14(16):e042186. doi: 10.1161/JAHA.125.042186. Epub 2025 Aug 12.
Ginsenoside Rg1 ameliorates hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and inflammation by regulating CCN1.
Tang BL, Liu Y, Zhang JL, Lu ML, Wang HX.
Biomed Pharmacother. 2023 Aug;164:114920. doi: 10.1016/j.biopha.2023.114920. Epub 2023 May 20.
Pulmonary hypertension associated with chronic hypoxia: just ASIC-ness?
Aaronson PI.
J Physiol. 2021 Nov;599(21):4731-4732. doi: 10.1113/JP282325. Epub 2021 Sep 30.
Macrophages: key conductors behind perivascular inflammation and vascular remodeling in hypoxia-induced pulmonary hypertension.
Spiekerkoetter E.
J Clin Invest. 2025 Mar 17;135(6):e190957. doi: 10.1172/JCI190957.
